Table 2.
Pathogen | Locus/Gene | Function | Infection model |
Phenotype | Reference |
---|---|---|---|---|---|
Transportation | |||||
M. tuberculosis | ctpC | Inner membrane P1B-type ATPase, efflux | Human monocyte-derived macrophages | Decreased survival of mutant | [22] |
*E. coli | zntA | Inner membrane P1B-type ATPase, efflux | Human monocyte-derived macrophages | Decreased survival of mutant | [22] |
Neutrophils | Decreased survival of mutant | [51] | |||
Group A Streptococcus | czcD | CDF family transporter; efflux | Neutrophils | Decreased survival of mutant | [52,53] |
Invasive subcutaneous; humanized plasminogen transgenic mouse | Decreased initial lesion size, dissemination in blood, mortality of mice Decreased survival relative to wild-type in competitive infection | [52,53] | |||
S. Typhimurium | Salmonella pathogenicity island-1 | Delivery of bacterial effector molecules; unknown mechanism | Human monocyte-derived macrophages | Prevents co-localization of phagosomes with Zn-containing vesicles | [51] |
zntA and zitB | Inner membrane P1B-type ATPase and CDF family transporters, respectively; efflux | Competitive intraperitoneal challenge; mouse | Reduced recovery of ΔzntA ΔzitB mutant from liver and spleen | [58] | |
Regulation | |||||
S. pneumoniae | sczA | Transcriptional activator of Zn efflux; regulation of Zn homeostasis | Human monocyte-derived macrophages | Decreased survival of mutant | [61] |
Group A Streptococcus | gczA (sczA) | Transcriptional activator of Zn efflux; regulation of Zn homeostasis | Neutrophils | Decreased survival of mutant | [52] |
Invasive subcutaneous; humanized plasminogen transgenic mouse | Decreased mortality of mice | [52] |
Non-pathogenic, but providec as a model Gram-negative organism.